| Matthew James Mcgehee, MD | |
|
9600 Gross Point Rd Ste 1200, Skokie, IL 60076-1214 | |
| (847) 503-4500 | |
| (847) 657-5754 |
| Full Name | Matthew James Mcgehee |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 21 Years |
| Location | 9600 Gross Point Rd Ste 1200, Skokie, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215058607 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2081P2900X | Physical Medicine & Rehabilitation - Pain Medicine | 036167219 (Illinois) | Secondary |
| 208100000X | Physical Medicine & Rehabilitation | 036167219 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northshore University Healthsystem - Evanston Hospital | Evanston, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwest Surgical Specialists Pc | 4183527153 | 103 |
| Northwest Surgical Specialists Pc | 4183527153 | 103 |
| North Shore University Healthsystem Faculty Practice Associates | 2163334699 | 1751 |
News Archive
Takeda Pharmaceutical Company Limited (Takeda) has announced that Takeda Global Research & Development Center, Inc. submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for alogliptin (development code: SYR-322), a highly selective dipeptidyl peptidase-4 (DPP-4) inhibitor under investigation for the treatment of type 2 diabetes.
The number of new cases of thyroid cancer among women in the U.S. has increased over the past decade despite a decline among women in mortality rates for most cancers, according to a report released Wednesday by the North American Association of Central Cancer Registries, the National Cancer Institute, CDC and the American Cancer Society, Long Island Newsday reports.
Public disclosure of companies' pollution habits has been an effective method of reducing pollution in many countries. Similarly, research has shown that people's and firms' propensity to contribute to public good increases if their contributions are made public. Findings from the University of Gothenburg reveal that the expected positive effect of disclosure can sometimes be crowded out by other factors at play.
Around 100,000 Austrians suffer from Alzheimer's disease and 16,000 from Parkinson's. Experts estimate that, in view of the ageing population, these numbers are set to triple over the next 30 years.
› Verified 8 days ago
| Entity Name | Northwest Surgical Specialists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730118803 PECOS PAC ID: 4183527153 Enrollment ID: O20040128000538 |
News Archive
Takeda Pharmaceutical Company Limited (Takeda) has announced that Takeda Global Research & Development Center, Inc. submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for alogliptin (development code: SYR-322), a highly selective dipeptidyl peptidase-4 (DPP-4) inhibitor under investigation for the treatment of type 2 diabetes.
The number of new cases of thyroid cancer among women in the U.S. has increased over the past decade despite a decline among women in mortality rates for most cancers, according to a report released Wednesday by the North American Association of Central Cancer Registries, the National Cancer Institute, CDC and the American Cancer Society, Long Island Newsday reports.
Public disclosure of companies' pollution habits has been an effective method of reducing pollution in many countries. Similarly, research has shown that people's and firms' propensity to contribute to public good increases if their contributions are made public. Findings from the University of Gothenburg reveal that the expected positive effect of disclosure can sometimes be crowded out by other factors at play.
Around 100,000 Austrians suffer from Alzheimer's disease and 16,000 from Parkinson's. Experts estimate that, in view of the ageing population, these numbers are set to triple over the next 30 years.
› Verified 8 days ago
| Entity Name | Progressive Rehabilitation Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790760908 PECOS PAC ID: 3476547258 Enrollment ID: O20040413001850 |
News Archive
Takeda Pharmaceutical Company Limited (Takeda) has announced that Takeda Global Research & Development Center, Inc. submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for alogliptin (development code: SYR-322), a highly selective dipeptidyl peptidase-4 (DPP-4) inhibitor under investigation for the treatment of type 2 diabetes.
The number of new cases of thyroid cancer among women in the U.S. has increased over the past decade despite a decline among women in mortality rates for most cancers, according to a report released Wednesday by the North American Association of Central Cancer Registries, the National Cancer Institute, CDC and the American Cancer Society, Long Island Newsday reports.
Public disclosure of companies' pollution habits has been an effective method of reducing pollution in many countries. Similarly, research has shown that people's and firms' propensity to contribute to public good increases if their contributions are made public. Findings from the University of Gothenburg reveal that the expected positive effect of disclosure can sometimes be crowded out by other factors at play.
Around 100,000 Austrians suffer from Alzheimer's disease and 16,000 from Parkinson's. Experts estimate that, in view of the ageing population, these numbers are set to triple over the next 30 years.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew James Mcgehee, MD 9600 Gross Point Rd Ste 1200, Skokie, IL 60076-1214 Ph: (847) 503-4500 | Matthew James Mcgehee, MD 9600 Gross Point Rd Ste 1200, Skokie, IL 60076-1214 Ph: (847) 503-4500 |
News Archive
Takeda Pharmaceutical Company Limited (Takeda) has announced that Takeda Global Research & Development Center, Inc. submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for alogliptin (development code: SYR-322), a highly selective dipeptidyl peptidase-4 (DPP-4) inhibitor under investigation for the treatment of type 2 diabetes.
The number of new cases of thyroid cancer among women in the U.S. has increased over the past decade despite a decline among women in mortality rates for most cancers, according to a report released Wednesday by the North American Association of Central Cancer Registries, the National Cancer Institute, CDC and the American Cancer Society, Long Island Newsday reports.
Public disclosure of companies' pollution habits has been an effective method of reducing pollution in many countries. Similarly, research has shown that people's and firms' propensity to contribute to public good increases if their contributions are made public. Findings from the University of Gothenburg reveal that the expected positive effect of disclosure can sometimes be crowded out by other factors at play.
Around 100,000 Austrians suffer from Alzheimer's disease and 16,000 from Parkinson's. Experts estimate that, in view of the ageing population, these numbers are set to triple over the next 30 years.
› Verified 8 days ago
Dr. Rupak D Parikh, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 3920 Jerome Ave, Skokie, IL 60076 Phone: 847-800-2814 | |
Dr. Matthew Co, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 9650 Gross Point Rd, Skokie, IL 60076 Phone: 847-503-4249 | |
Dinora Ingberman, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 9669 Kenton Ave, Suite 405, Skokie, IL 60076 Phone: 630-789-2550 Fax: 847-675-7595 | |
Mr. Romil K Sood, PT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 8330 N. Lincoln Ave, Skokie, IL 60077 Phone: 847-983-8600 Fax: 847-983-4321 | |
George A. Kannankeril, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 9650 Gross Point Rd Ste 2900, Skokie, IL 60076 Phone: 847-503-4500 Fax: 847-657-5754 |